Alkylating Agents
Showing 1 - 25 of 5,451
Acute Myeloid Leukemia, MDS Trial in China (Fludarabine, busulfan and melphalan, Fludarabine and Busulfan)
Active, not recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- Fludarabine, busulfan and melphalan
- Fludarabine and Busulfan
-
Fuzhou, Fujian, China
- +8 more
Aug 14, 2023
Neuroendocrine Tumors Trial in France (Oxaliplatin-based chemo, Alkylating-based chemo)
Active, not recruiting
- Neuroendocrine Tumors
- Oxaliplatin-based chemotherapy
- Alkylating-based chemotherapy
-
Amiens, France
- +18 more
Mar 15, 2022
Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in United States (CYNK-001)
Recruiting
- Leukemia
- +19 more
- CYNK-001
-
Denver, Colorado
- +9 more
Sep 9, 2022
Cancer, Toxicity Due to Chemo, Sarcoma Trial in Le Kremlin Bicêtre (Triptorelin (GnRHa) + Chemotherapy)
Unknown status
- Cancer
- +5 more
- Triptorelin (GnRHa) + Chemotherapy
-
Le Kremlin Bicêtre, FranceAP-HP, Bicêtre Hospital
Dec 16, 2019
Drug Induced Neuropathy in Children With ALL
Recruiting
- Acute Lymphocytic Leukemia
-
Trieste, Friuli Venezia Giulia, ItalyIRCCS materno infantile Burlo Garofolo
Mar 31, 2023
Acute Myeloid Leukemia (AML) in Remission, Stem Cell Transplantation Trial in Worldwide (busulfan, cyclophosphamide and
Recruiting
- Acute Myeloid Leukemia (AML) in Remission
- Stem Cell Transplantation
- busulfan, cyclophosphamide and melphalan, BuCyMel
- clofarabine, fludarabine and busulfan, CloFluBu
-
Brussels, Belgium
- +16 more
Jul 25, 2022
Breast Cancer Trial in Netherlands (Carboplatin and Paclitaxel, Doxorubicin, cyclophosphamide, Doxorubicin, cyclophosphamide,
Active, not recruiting
- Breast Cancer
- Carboplatin and Paclitaxel
- +2 more
-
Alkmaar, Netherlands
- +13 more
Oct 18, 2021
Breast Cancer Trial in Amsterdam (carboplatin, thiotepa, and cyclophosphamide, chemo (docetaxel, doxorubicin, cyclofosfamide,
Recruiting
- Breast Cancer
- carboplatin, thiotepa, and cyclophosphamide
- chemotherapy (docetaxel, doxorubicin, cyclofosfamide, carboplatin, paclitaxel, gemcitabine)
-
Amsterdam, NetherlandsNKI-AVL
Mar 21, 2022
HER2 Positive Early Breast Cancer Trial in Shanghai (Docetaxel, carboplatin, Trastuzumab)
Recruiting
- HER2 Positive Early Breast Cancer
- Docetaxel
- +5 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center Shanghai, China, 200032
Jun 6, 2023
Rectal Cancer Trial in Milan (External-beam radiation, Capecitabine, Temozolomide)
Recruiting
- Rectal Cancer
- External-beam radiation
- +2 more
-
Milan, ItalyFondazione IRCCS Istituto Nazionale dei Tumori
Jan 25, 2022
Metastatic Colorectal Cancer Trial in Milan (Temozolomide, Nivolumab, Ipilimumab)
Completed
- Metastatic Colorectal Cancer
- Temozolomide
- +2 more
-
Milan, MI, ItalyFondazione IRCCS Istituto Nazionale dei Tumori
Apr 1, 2022
Urothelial Carcinoma, Urothelial Carcinoma Recurrent, Urothelial Carcinoma Ureter Trial (Jelmyto (mitomycin) for pyelocalyceal
Not yet recruiting
- Urothelial Carcinoma
- +7 more
- Jelmyto (mitomycin) for pyelocalyceal solution
- (no location specified)
May 22, 2023
Ovarian Cancer Trial in Maywood (Decitabine, Carboplatin, Paclitaxel)
Not yet recruiting
- Ovarian Cancer
- Decitabine
- +3 more
-
Maywood, IllinoisLoyola University Medical Center
Aug 1, 2023
Adult Diffuse Large Cell Lymphoma, Recurrent, Adult Refractory DLBCL Trial in Canada (DPX-Survivac, Pembrolizumab,
Active, not recruiting
- Adult Diffuse Large Cell Lymphoma
- +2 more
- DPX-Survivac
- +2 more
-
Calgary, Alberta, Canada
- +5 more
Nov 9, 2022
Hodgkin Lymphoma Trial in Italy, United States (Rituximab, Involved field irradiation)
Terminated
- Hodgkin Lymphoma
- Rituximab
- Involved field irradiation
-
Houston, Texas
- +10 more
Aug 18, 2021
Metastatic Colorectal Cancer Trial in Milan (Bevacizumab, Irinotecan, Leucovorin)
Recruiting
- Metastatic Colorectal Cancer
- Bevacizumab
- +4 more
-
Milan, ItalyFondazione IRCCS Istituto Nazionale dei Tumori
Apr 1, 2022
Short Term Genetic Effects of Chemotherapy on Male Germ Cells
Recruiting
- Cancer
- Semen collection and analysis
-
Pittsburgh, PennsylvaniaMagee-Womens Hospital
May 19, 2022
Squamous Cell Carcinoma of the Head and Neck Trial in Tampa (Cisplatin, Stereotactic Body Radiation Therapy (SBRT))
Active, not recruiting
- Squamous Cell Carcinoma of the Head and Neck
- Cisplatin
- Stereotactic Body Radiation Therapy (SBRT)
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Mar 22, 2022
Glioma, Gliomas, High Grade Glioma Trial run by the National Cancer Institute (NCI) (3T MRI scanner)
Recruiting
- Glioma
- +4 more
- 3T MRI scanner
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Idiopathic Membranous Nephropathy
Not yet recruiting
- Idiopathic Membranous Nephropathy
- Obinutuzumab Injection
- (no location specified)
May 8, 2023
Amyloidosis Trial in Athens (Lenalidomide, Dexamethasone and Cyclophosphamide)
Completed
- Amyloidosis
- Lenalidomide, Dexamethasone and Cyclophosphamide
-
Athens, Attica, GreeceAlexandra Hospital , Department of Clinical Therapeutics
Apr 27, 2021